MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
527.78
-19.89
-3.63%
After Hours: 529.00 +1.22 +0.23% 19:36 05/09 EDT
OPEN
549.00
PREV CLOSE
547.67
HIGH
552.84
LOW
527.13
VOLUME
1.50M
TURNOVER
--
52 WEEK HIGH
1,209.65
52 WEEK LOW
520.50
MARKET CAP
56.98B
P/E (TTM)
13.43
1D
5D
1M
3M
1Y
5Y
1D
Regeneron Pharmaceuticals (NasdaqGS:REGN) Reports Q1 2025 Revenue Drop to US$3,029 Million
Simply Wall St · 21h ago
What Moved Markets This Week
Seeking Alpha · 1d ago
Regeneron Pharmaceuticals Inc. Stock Slips 3.6%, Underperforms Competitors
Dow Jones · 1d ago
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
MarketWatch · 1d ago
Benjamin Graham Detailed Fundamental Analysis - REGN
NASDAQ · 1d ago
Intellia's Q1 Loss Narrower Than Expected, Pipeline in Focus, Stock Up
NASDAQ · 1d ago
Interesting REGN Put And Call Options For July 18th
NASDAQ · 2d ago
1 Cash-Heavy Stock on Our Buy List and 2 to Ignore
Barchart · 2d ago
More
About REGN
More
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.
Recently
Symbol
Price
%Change

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.